Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Labviva Announces $8M Series Seed Capital Raise

Company’s Enterprise Gateway Marketplace is Transforming Life Sciences Procurement

Labviva, a leading SaaS application for healthcare procurement today announced an $8M Series Seed capital raise to support further development of the platform with new product lines, including investment in operations and customer success platforms. The funding closed on June 2, 2021. Led by Senator Investment Group, with other new investment from B Capital Group | Ascent and continued participation from Glasswing Ventures which led previous rounds to date.

Labviva is an enterprise gateway marketplace (EGM) that integrates with major procurement solutions such as SAP Ariba, JAGGAER, Oracle Procurement Cloud, Microsoft Dynamics 365, and Coupa. Organizations like pharmaceuticals and research institutions can coordinate their demand with the thousands of outside vendors who fulfill on the supply side. In addition, Labviva’s platform provides deep scientific insight about the products and allows customers to have access to advanced analytics typically not offered by incumbent suppliers.

The platform gives purchasers of lab supplies, reagents, consumables, and laboratory equipment the ability to source from any supplier in the extensive Labviva network without individually onboarding each vendor. Functionality like intuitive search and comparison shopping provides users with a consumer-like shopping experience in a laboratory setting.

“Because of their ability to penetrate some of the most well-known pharma, biotech, and research organizations in North America, we placed a high valuation on Labviva,” said Evan Lodes, Partner at Senator Investment Group. “The push for modernization across the procurement industry and in the life sciences vertical is stronger than ever. Labviva is leading in this space.”

“Having been an investor in Labviva since its inception, we recognize the team’s deep understanding of the buying process in the scientific space,” said Sarah Fay, Managing Director at Glasswing Ventures. “The platform the team has built promises to significantly optimize buying channels without disrupting business processes – a very appealing proposition to procurement directors.”

Unique to Labviva is a proprietary AI engine that offers scientific context. The platform connects researchers to suppliers of reagents, chemicals, and instrumentation products that are mapped to scientific applications and protocols. Researchers are able to easily understand if items are appropriate for their research. Updates are dynamic, as the engine constantly searches public databases for new citations and protocols.

At the same time, purchasing departments are ensured compliance, as their rules and governance remain in place. Procurement professionals are able to access advanced analytics to give visibility into spending metrics and trends. The platform reduces the process of manually uploading supplier product catalogs and the associated e-commerce data.

“We built the Labviva platform with full view of the life sciences ecosystem in mind,” said Siamak Baharloo, CEO and Co-Founder of Labviva. “We want to enable procurement and suppliers to be able to better work together, but at the heart of the technology is empowering scientists.”

This is the second major capital raise for Labviva, which was founded in 2017 by industry veterans Baharloo, Aaron Miramontes, and Nicholas Rioux. The company raised over $2M in pre-seed funding in 2020.

The Labviva approach helps improve the relationship between suppliers and manufacturers of life sciences products and enterprise purchasers. It also supports access to in-demand products by connecting more diverse pool of suppliers to scientists. The revenue model is subscription based.

All brands are the properties of their respective owners.

About Labviva

Labviva connects researchers with suppliers of reagents, chemicals, and instrumentation in an intuitive user-friendly platform that supports the priorities of scientists while staying compliant with purchasing rules. Suppliers can easily manage their content of their products, and products are mapped into scientific applications, techniques and protocols. Learn more about how Labviva accelerates the science of life at Labviva.com

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.